Cocrystal Pharma initiated enrollment in phase 1 influenza a study with novel, broad-spectrum, orally administrated antiviral CC-42344
On Mar. 10, 2022, Cocrystal Pharma announced dosing of the first subjects in a Phase 1 clinical trial…
-
-
City of Hope COVID-19 vaccine showed effectiveness in phase 1 trial
On Mar. 10, 2022, a COVID-19 investigational vaccine, developed by City of Hope scientists and now licensed to…
-
After more than 20 years, scientists solved the full-length structure of a Janus Kinase
On Mar. 10, 2022, Howard Hughes Medical Institute announced that after more than two decades of effort researchers…
-
International team created first complete fruit fly cell atlas
On Mar. 9, 2022, Harvard Medical School announced that an international research team had completed an atlas of…
-
NIH launched trial to study allergic reactions to COVID-19 mRNA vaccine
On Mar. 9, 2022, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) announced a clinical…
-
Pfizer initiated phase 2/3 study of novel COVID-19 oral treatment in pediatric participants
On Mar. 9, 2022, Pfizer announced that it had initiated a Phase 2/3 study, EPIC-PEDS (Evaluation of Protease…
-
U.S. EPA approved Oxitec Mosquito Pilot Projects in California and Florida
On Mar. 4, 2022, Oxitec announced the publication by the U.S. Environmental Protection Agency of its approval to…
-
Moderna announced MOU with Government of Kenya to establish first mRNA manufacturing facility on the continent of Africa
On Mar. 7, 2022, Moderna announced that with the assistance of the U.S. Government, it had entered into…
-
FDA | Genomics | Veterinary
FDA made low-risk determination for marketing of products from genome-edited beef cattle after safety review
On Mar. 7, 2022, the U.S. Food and Drug Administration (FDA) announced it had made a low-risk determination…
-
Innovation Pharmaceuticals reported additional findings from Brilacidin phase 2 COVID-19 tial results
On Mar. 7, 2022, Innovation Pharma announced the Company was conducting full data analysis of the Phase 2…
-
University of Oxford reported brain regions related to smell show decline following mild COVID-19
On Mar. 7, 2022, researchers from the University of Oxford have used data from UK Biobank participants to…
-
CDC reported disparities in COVID-19 vaccination coverage between urban and rural counties
On Mar. 4, 2022, the U.S. Centers for Disease Control and Prevention (CDC) reported that COVID-19 vaccination coverage with…
-
First-ever malaria vaccine recommendation published in a position paper and in the WHO guidelines for malaria
On Mar. 4, 2022, the WHO announced it had published an updated position paper on the RTS,S/AS01 (RTS,S)…
-
USDA confirmed highlypathogenic Avian influenza in flock of commercial broiler chickens in Missouri
On Mar. 4, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
-
Possible case of deer-to-human SARS-CoV-2 transmission
On Mar. 3, 2022, a study carried out in southwestern Ontario identified a highly mutated variant of SARS-CoV-2…
-
COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine | WHO
WHO and MPP welcomed NIH’s offer of COVID-19 health technologies to C-TAP
On Mar. 3, 2022, the World Health Organization (WHO) and the Medicines Patent Pool (MPP) jointly welcomed the announcement…
-
Roche announced donation of essential medicines to Ukraine
On Mar. 2, 2022, Roche announced an initial donation of essential medicines to Ukraine. Roche is working diligently…
-
Agriculture | Biotechnology | Diagnostics | Disease | Infectious Disease | Influenza | Therapeutics | USDA | Vaccine
Iowa Department of Agriculture and USDA Confirm Case of Highly Pathogenic Avian Influenza in Non-Commercial Backyard Flock
On Mar. 2, 2022, the Iowa Department of Agriculture and Land Stewardship and the United States Department of…
-
Biotechnology | COVID-19 | FDA | Therapeutics
Sorrento announced FDA authorization to proceed with phase 1 study of Intranasal STI-9199 against Covid-19 viruses
On Mar. 2, 2022, Sorrento Therapeutics announced that its Phase I study of intranasal (IN) STI-9199 (COVISHIELDTM IN) has…
-
Sorrento announced COVISHIELD antibody nasal drops prevent productive SARS-CoV-2 infections
On Mar. 2, 2022, Sorrento Therapeutics announced that new preclinical results demonstrated that pretreating an animal with intranasal…
-
British Columbia Officials confirm highly pathogenic avian influenza in the Pacific Flyway
On Mar. 2, 2022, British Columbia officials announced it was working to prevent highly pathogenic avian influenza from infecting…
-
Agriculture | Biotechnology | CRISPR | Genomics | USDA
Yield10 Bioscience Field Test Results Show Seed Oil Content Increase in Camelina and Canola
On Mar. 1, 2022, Yield10 Bioscience announced that 2021 field test results showed that the trait C3020 tested…
-
CDC reported effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19 among children and adolescents
On Mar. 1, 2022, the U.S. Centers for Disease Control and Prevention (CDC) reported that two doses of Pfizer-BioNTech…
-
Biotechnology | CRISPR | Disease | Genomics | Therapeutics
U.S. patent appeal board ruled against University of California in CRISPR interference
On Feb. 28, 2022, the Patent and Trial Appeal Board of the U.S. Patent and Trademark Office (USPTO)…
-
Possible case of deer-to-human SARS-CoV-2 transmission
On Feb. 25, 2022, researchers announced that wildlife reservoirs of SARS-CoV-2 can lead to viral adaptation and spillback…
-
EMA’s Committee for Medicinal Products for Human Use recommended authorization of Covid-19 vaccine in children (6-11 Years) In the EU
On Feb. 24, 2022, Moderna announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use…
-
USDA confirmed highly pathogenic Avian influenza in a non-commercial backyard flock in Michigan
On Feb. 24, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
-
Pfizer and BioNTech received positive CHMP Opinion for COVID-19 vaccine booster in adolescents 12 through 17 years of age in EU
On Feb. 24, 2022, BioNTech announced that the Committee for Medicinal Products for Human Use of the European…
-
Medicago and GSK announced approval by Health Canada of COVIFENZ, an adjuvanted plant-based COVID-19 vaccine
On Feb. 24, 2022, Medicago and GlaxoSmithKline announced that Health Canada had granted approval for COVIFENZ, COVID-19 vaccine,…
-
University of Oxford researchers created largest ever human family tree
On Feb. 24, 2022, researchers from the University of Oxford have used data from UK Biobank participants to…
